IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.356
NA - Nord America 8.241
AS - Asia 3.609
SA - Sud America 460
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 11
Totale 21.738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.769
RU - Federazione Russa 4.122
SG - Singapore 2.138
IT - Italia 1.864
GB - Regno Unito 1.172
DE - Germania 638
HK - Hong Kong 610
CA - Canada 444
IE - Irlanda 421
BR - Brasile 403
UA - Ucraina 397
CN - Cina 347
VN - Vietnam 223
SE - Svezia 179
FI - Finlandia 147
NL - Olanda 84
AT - Austria 68
FR - Francia 65
DK - Danimarca 64
PK - Pakistan 54
ID - Indonesia 52
IN - India 47
BD - Bangladesh 22
CH - Svizzera 22
AR - Argentina 21
BE - Belgio 20
ES - Italia 17
EU - Europa 17
RO - Romania 17
LT - Lituania 15
TR - Turchia 15
IR - Iran 14
JP - Giappone 12
MX - Messico 12
CO - Colombia 11
CZ - Repubblica Ceca 11
MA - Marocco 10
AU - Australia 9
PL - Polonia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
EG - Egitto 8
AM - Armenia 6
AZ - Azerbaigian 6
VE - Venezuela 6
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
TW - Taiwan 5
ZA - Sudafrica 5
CL - Cile 4
GE - Georgia 4
MY - Malesia 4
PE - Perù 4
TH - Thailandia 4
CI - Costa d'Avorio 3
GT - Guatemala 3
HU - Ungheria 3
IQ - Iraq 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
NI - Nicaragua 3
PH - Filippine 3
SA - Arabia Saudita 3
AO - Angola 2
CR - Costa Rica 2
DZ - Algeria 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
MT - Malta 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 21.735
Salva come PNG Salva come JPEG
Città #
Singapore 962
Chandler 562
Hong Kong 557
Southend 543
Fairfield 462
San Mateo 451
Moscow 433
Dublin 417
Woodbridge 356
Houston 319
Cambridge 316
Chicago 307
Seattle 264
Wilmington 262
The Dalles 254
Falls Church 237
Ashburn 231
Boardman 231
Portsmouth 227
Stevenage 215
Ann Arbor 212
Ottawa 202
Beauharnois 193
Jacksonville 175
Pisa 171
Los Angeles 170
Milan 167
Dearborn 156
Lawrence 155
Rome 152
Salt Lake City 146
Tampa 120
Dong Ket 117
Santa Clara 117
Beijing 110
Florence 99
Buffalo 87
Helsinki 77
Nuremberg 76
London 65
Elk Grove Village 64
San Diego 64
Munich 55
Lappeenranta 48
Brooklyn 42
Fremont 38
Bologna 35
Genoa 35
Sterling 35
Central District 34
Lucca 34
Lancaster 33
Livorno 33
Palermo 33
São Paulo 31
Vienna 31
Dallas 30
Washington 30
Naples 28
Assago 26
Frankfurt am Main 26
Redwood City 26
Toronto 25
Norwalk 23
Shanghai 22
Dulles 21
Old Bridge 21
Bari 19
Brussels 19
Buti 19
Guangzhou 18
Padova 18
Belo Horizonte 17
Redmond 17
Shenzhen 17
Verona 16
Islamabad 15
New York 15
Turin 14
Zhengzhou 14
Amsterdam 13
Hounslow 13
Medolago 13
Rio de Janeiro 13
Nanjing 12
West Jordan 12
Chiswick 11
Council Bluffs 11
Detroit 11
Faisalabad 11
Forlì 11
Parma 11
Venice 11
Bucharest 10
Cascina 10
Catania 10
Dongguan 10
Kansas City 10
Miami 10
Brasília 9
Totale 11.736
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 506
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 431
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 367
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 248
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 234
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 211
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 206
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 202
Treating chemoreflex in heart failure: modulation or demolition? 196
Building medical knowledge from real world registries: The case of heart failure 196
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 191
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 190
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 182
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 180
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 180
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 178
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 177
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 171
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 164
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 160
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 158
Cardiac light-chain deposition disease relapsing in the transplanted heart 153
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 152
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 146
Sex-related differences in chronic heart failure 143
A simple echocardiographic score to rule out cardiac amyloidosis 143
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 142
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 137
How to take arms against central apneas in heart failure 136
Unmet needs in end-of-life care for heart failure patients 133
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 128
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 126
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 125
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 121
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 120
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 119
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 116
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 116
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 114
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 114
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart 111
Heart, kidney and FGF23: Les liaisons dangereuses 111
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 111
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 110
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 110
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure 108
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 108
Cardiac troponins as biomarkers for cardiac disease 108
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 107
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 105
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 105
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 105
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 104
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 100
Amiodarone as a possible therapy for coronavirus infection 100
Management of complications of cardiac amyloidosis: 10 questions and answers 99
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 98
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 98
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 97
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 96
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 95
Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies 95
The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) 95
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 94
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure 93
A simple echocardiographic score to rule out cardiac amyloidosis 92
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 92
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 91
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 91
Atrial amyloidosis: mechanisms and clinical manifestations 89
Therapies for cardiac light chain amyloidosis: An update 89
Sex-related differences in chronic heart failure 89
Screening the health status of people working in a university 88
Biomarkers for the diagnosis and management of heart failure 88
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 88
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 86
Left ventricular ejection fraction for risk stratification in chronic systolic heart failure 85
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 85
Quality of life and outcome in heart failure with preserved ejection fraction: When sex matters 84
Cardiovascular disease and COVID-19: les liaisons dangereuses 84
Molecular autopsy of sudden cardiac death in the genomics era 83
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 82
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 82
Role of Imaging in Cardiomyopathies 81
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome 81
Biomarkers for the diagnosis and management of heart failure: New frontiers 81
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 81
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 79
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 78
How much is it to mend a broken heart? Results from the US Nationwide Readmission Database 78
Subclinical cardiac damage in cancer patients before chemotherapy 78
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 78
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 77
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 77
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 77
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 77
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 76
Eligibility for vericiguat in a real‐world, contemporary heart failure population 75
Treatment of cardiac transthyretin amyloidosis: an update 75
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 75
Totale 12.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 0 0 0 0 0 24 42 94
2020/20212.357 195 209 96 208 108 321 143 129 217 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202511.629 220 243 878 362 665 803 1.951 3.264 1.352 1.891 0 0
Totale 22.094